What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction

Anaphylaxis Clinical Trial

— SAPRA  

Official title:

What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03942692
• Other study ID #: 69HCL18_0493
• Status: Completed
• Start date: May 21, 2019
• Est. completion date: August 20, 2019

Study information

• Verified date: October 2019
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Anaphylaxis is an allergic reaction potentially fatal. The treatment is based on injection of epinephrin as soon as possible. Guidelines by the World Allergic Organisation highlight the importance of medical follow-up. This follow-up consists of an allergy consultation, the prescription and demonstration of epinephrin auto-injector and the implementation of specific measures in schools. There is no study about the recurrence of anaphylactic reaction outside the hospital.

The purpose of this study is to evaluate the allergy follow-up of children after anaphylactic reaction. The secondary objective is to evaluate the use of medical advice in case of recurrence of anaphylactic reaction.

Investigators will use a phone call questionnaire for parents of children who underwent an anaphylactic reaction between the 1st July 2014 and the 31st June 2016 treated in the Paediatric Emergency Department in Femme-Mère-Enfant Hospital in Lyon in France. 179 children could be included in the study.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 118
• Est. completion date: August 20, 2019
• Est. primary completion date: August 20, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 18 Years

Eligibility

Inclusion Criteria:

• Age from 0 to 17

• Anaphylactic reaction meeting the criteria of Sampson et al. treated in Paediatric Emergency Department of Femme-Mère-Enfant Hospital in Lyon in France

• Anaphylactic reaction treated between the 1st July 2014 and the 31st June 2016

Exclusion Criteria:

• No agreement from patient or parents to participate in the study

Related Conditions & MeSH terms

• Allergic Reaction
• Anaphylaxis
• Hypersensitivity
• Shock

Intervention

Other:
• Phone call questionnaire
Questionnaire for parents of subject about : the frequency of consultations with an allergist the information of the general practitioner or pediatrician the prescription of epinephrin auto-injector the frequency of renewal of epinephrin auto-injector the specialty of doctor who prescribed the renewal the implementation of specific measures in schools the frequency of renewal of specific measures in schools the number of recurrence of anaphylactic reaction the use of medical advice in case of recurrence of anaphylactic reaction

Locations

Country	Name	City	State
France	Paediatric Emergency Department in Femme-Mère-Enfant Hospital	Bron

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Allergy follow-up	Allergy follow-up evaluation with : the frequency of consultations with an allergist; the information of the general practitioner or pediatrician; the prescription of epinephrin auto-injector; the frequency of renewal of epinephrin auto-injector; the specialty of doctor who prescribed the renewal; the implementation of specific measures in schools; the frequency of renewal of specific measures in schools; the number of recurrence of anaphylactic reaction; the use of medical advice in case of recurrence of anaphylactic reaction	About 15 minutes